DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Funding Opportunity Number: HT942526TSCRPCTRA

About the Opportunity

The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will advance promising preclinical and/or clinical research findings toward clinical application, including diagnosis, prognosis, or treatment of tuberous sclerosis complex (TSC).

Distinctive Features

• Allows for multiple Principal Investigators (PIs). Only the initiating PI submits a pre-application, but all PIs must submit full applications.
• The partnering PI(s) submit an abbreviated package specific to their distinct portion of the research project.
• All associated applications for a research project may be withdrawn if the initiating or any partnering application is rejected or administratively withdrawn.

Eligibility

Unrestricted (open to any type of entity), subject to any clarification in the "Additional Information on Eligibility" section.

Funding Details

• Expected number of awards: 2
• Estimated total program funding: $3,500,000
• Cost sharing or matching requirement: No

Key Dates

• Posted Date: May 05, 2026
• Current Closing Date for Applications: August 06, 2026
• Archive Date: September 12, 2026

Additional Information

Assistance Listing: 12.420 -- Military Medical Research and Development

For further details or assistance, contact the eBRAP Help Desk at help@eBRAP.org or (301) 682-5507.